A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial
2015 ◽
Vol 16
(5-6)
◽
pp. 353-358
◽
2017 ◽
Vol 37
(11)
◽
pp. 1083-1091
◽
2011 ◽
Vol 84
(2)
◽
pp. 255-260
◽
2017 ◽
Vol 45
(4)
◽
pp. 418-425
◽
2018 ◽
Vol 49
◽
pp. 84-90
◽
2013 ◽
Vol 4
(3)
◽
pp. 205
◽
2009 ◽
Vol 11
(7)
◽
pp. 700-708
◽